Diabetes and cancer I: risk, survival, and implications for screening.
about
Hyperglycemia as a risk factor for cancer progressionTumor macroenvironment and metabolism.Genomic profiling of type-1 adult diabetic and aged normoglycemic mouse liver.A novel method for studying the temporal relationship between type 2 diabetes mellitus and cancer using the electronic medical recordSignificantly higher rates of multiple and proximally located adenomas among patients with diabetes mellitus: A cross-sectional population-based studyDiabetes and cancer: Associations, mechanisms, and implications for medical practice.Increased cancer incidence risk in type 2 diabetes mellitus: results from a cohort study in Tyrol/Austria.Association of cancer susceptibility variants with risk of multiple primary cancers: The population architecture using genomics and epidemiology study.Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant StressComparison of adipose tissue- and bone marrow- derived mesenchymal stem cells for alleviating doxorubicin-induced cardiac dysfunction in diabetic rats.Association of diabetes and cancer mortality in American Indians: the Strong Heart StudyMetformin and cancer in type 2 diabetes.Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcersProstate cancer risk in pre-diabetic men: a matched cohort study.Diabetes, diabetes treatment, and mammographic density in Danish Diet, Cancer, and Health cohort.The elevated preoperative fasting blood glucose predicts a poor prognosis in patients with esophageal squamous cell carcinoma: The Fujian prospective investigation of cancer (FIESTA) study.An Elevated HbA1c Level Is Associated With Short-Term Adverse Outcomes in Patients With Gastrointestinal Cancer and Type 2 Diabetes Mellitus.Silencing vimentin expression decreases pulmonary metastases in a pre-diabetic mouse model of mammary tumor progression.Risk of cause-specific death in individuals with cancer - modifying role diabetes, statins, and metformin.When fat becomes an ally of the enemy: adipose tissue as collaborator in human breast cancer.The association of diabetes and obesity with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study.Use of statins offsets insulin-related cancer risk.EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice.Incidence of Diabetes in Colorectal Cancer Survivors.Diabetic biomarkers and the risk of proximal or distal gastric cancer.The temporal relationship between diabetes and cancer: A population-based study.The growing prevalence of type 2 diabetes: increased incidence or improved survival?Diabetes and colorectal cancer screening among men and women in the USA: National Health Interview Survey: 2008, 2010.The excess mortality related to cardiovascular diseases and cancer among adults pharmacologically treated for diabetes--the 2001-2006 ENTRED cohort.Influence of diabetes mellitus on mortality in breast cancer patients.A cohort study of digoxin exposure and mortality in men with prostate cancer.Prognostic Significance of Hyperglycemia in Patients with Brain Tumors: a Meta-Analysis.Comorbidity, Physical Function, and Quality of Life in Older Adults with Acute Myeloid Leukemia.Insulin/IGF-driven cancer cell-stroma crosstalk as a novel therapeutic target in pancreatic cancer.The effect of glycemic control on CEA, CA 19-9, amylase and lipase levels.Plasma insulin, C-peptide and blood glucose and the risk of gastric cancer: the Japan Public Health Center-based prospective study.The fasting blood glucose and long non-coding RNA SNHG8 predict poor prognosis in patients with gastric carcinoma after radical gastrectomy
P2860
Q27687614-63CEF1DD-D622-46A9-B7B3-1B7F31F4683DQ33574461-88FAF59C-52DF-49C4-A5F4-E0E6E74743D8Q33592783-ECFFEB4E-0212-44E2-84E4-80C3CFBCCC2FQ33617565-48DC1F15-B709-4FAB-ACC4-FA1B3A7B1287Q33632980-67828CC8-AE63-4431-B332-5788B822B0CEQ33759594-72EB55CB-2580-427B-B29E-1DA0FF185E47Q34355418-C37ABA5D-DD05-4883-8B42-C44968E4FF08Q34457646-3A28E0F1-44D7-4D70-AE02-445970F663D0Q35782187-07A8B74B-ECBE-4182-8BD5-4386C98FE881Q35987027-79ECB226-E3A7-4CD3-8861-E02850A2B87AQ36133307-4F6A552A-FD3B-4D0D-A5C6-F0B46B07F0BEQ36800716-7BBC21CF-868B-46BB-B6EA-1E59665776ABQ37352092-C823A1CB-453E-4FAE-85F5-392D8CFB3E05Q37568435-B2C7C0DF-3816-453F-84AA-5EDFC6C31446Q37568800-57E6A104-96B2-4383-A42A-64DAE6F78F0FQ37662211-5C97100F-984F-4E12-889C-C763EE9F9D42Q37672164-37232A09-5CA0-4AC9-82EE-04B4D4797BE5Q37675705-CD9B62A9-3801-42FE-A326-2FAE102CAAFBQ38398847-ECE39F5A-2013-46AD-BD9D-33CCC345ECE0Q38543908-119DA012-8C67-4F39-B8EE-78F10C0CA3E7Q39199949-D3FA84D7-F59F-4358-8060-FA0A0FE0598FQ39263827-9CF07DA6-8EB9-4344-86A1-4AA561E4D24AQ39584487-72B19B32-1059-4167-A196-C9FF08B37BB5Q40029244-EF77B38E-0182-4F62-9DD7-131037E98E4CQ40511318-CFFA6EC7-8257-4E0B-A3B0-7E10E4C3A8F3Q40657968-A63177EE-59C7-4B0E-80E1-2B7B4FD9ECE4Q42246344-60449448-BB2A-413F-98A0-663165CDB524Q44377731-F46D8664-66A9-429D-9F03-7EAC580E569DQ44392359-66436EE2-2E9C-4B3E-8613-7171FE9599ABQ45908971-D77D287F-C5E5-4974-9105-31E263EA255BQ47797325-61647EF8-223C-4FB7-B125-CAB00EEBBAACQ48325616-C6357738-620B-466D-A2D4-479413940B31Q50234387-805E3FDD-5C64-409D-BCFD-590593DB18BAQ50314975-6503A2B5-C3DA-4F91-8911-E8CF47954C34Q51315812-C6E5F7C4-C10B-4CA2-8C1C-308DF303A94CQ51318238-9BB9A5F2-64ED-4724-AA3B-01F2326B7C33Q57296698-EF2A381D-FC2C-43FE-A020-DB0CDE6EF4B5
P2860
Diabetes and cancer I: risk, survival, and implications for screening.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Diabetes and cancer I: risk, survival, and implications for screening.
@ast
Diabetes and cancer I: risk, survival, and implications for screening.
@en
Diabetes and cancer I: risk, survival, and implications for screening.
@nl
type
label
Diabetes and cancer I: risk, survival, and implications for screening.
@ast
Diabetes and cancer I: risk, survival, and implications for screening.
@en
Diabetes and cancer I: risk, survival, and implications for screening.
@nl
prefLabel
Diabetes and cancer I: risk, survival, and implications for screening.
@ast
Diabetes and cancer I: risk, survival, and implications for screening.
@en
Diabetes and cancer I: risk, survival, and implications for screening.
@nl
P2093
P2860
P1476
Diabetes and cancer I: risk, survival, and implications for screening.
@en
P2093
Adedayo A Onitilo
Gail M Williams
Ingrid Glurich
Jessica M Engel
Rachel V Stankowski
Suhail A Doi
P2860
P2888
P304
P356
10.1007/S10552-012-9972-3
P407
P577
2012-05-03T00:00:00Z